Works by Kim, Dong-Wan


Results: 217
    1

    Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study.

    Published in:
    2021
    By:
    • Park, Keunchil;
    • Jӓnne, Pasi A.;
    • Kim, Dong‐Wan;
    • Han, Ji‐Youn;
    • Wu, Ming‐Fang;
    • Lee, Jong‐Seok;
    • Kang, Jin‐Hyoung;
    • Lee, Dae Ho;
    • Cho, Byoung Chul;
    • Yu, Chong‐Jen;
    • Pang, Yong Kek;
    • Felip, Enriqueta;
    • Kim, Hyunjin;
    • Baek, Eunhye;
    • Noh, Young Su;
    • Kim, Dong-Wan;
    • Han, Ji-Youn;
    • Wu, Ming-Fang;
    • Lee, Jong-Seok;
    • Kang, Jin-Hyoung
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies.

    Published in:
    Lung Cancer: Targets & Therapy, 2019, v. 10, p. 125, doi. 10.2147/LCTT.S209231
    By:
    • Gadgeel, Shirish;
    • Shaw, Alice T;
    • Barlesi, Fabrice;
    • Crino, Lucio;
    • Yang, James CH;
    • Dingemans, Anne-Marie;
    • Kim, Dong-Wan;
    • Marinis, Filippo de;
    • Schulz, Mathias;
    • Liu, Shiyao;
    • Gupta, Ravindra;
    • Smoljanovic, Vlatka;
    • Ou, Sai-Hong Ignatius
    Publication type:
    Article
    19
    20
    21
    22
    23

    Aggressiveness of Cancer-Care near the End-of-Life in Korea.

    Published in:
    Japanese Journal of Clinical Oncology, 2008, v. 38, n. 5, p. 381, doi. 10.1093/jjco/hyn031
    By:
    • Keam, Bhumsuk;
    • Oh, Do-Youn;
    • Lee, Se-Hoon;
    • Kim, Dong-Wan;
    • Kim, Mi Ra;
    • Im, Seock-Ah;
    • Kim, Tae-You;
    • Bang, Yung-Jue;
    • Heo, Dae Seog
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)

    Published in:
    Cancers, 2023, v. 15, n. 20, p. 4999, doi. 10.3390/cancers15204999
    By:
    • Ang, Yvonne L. E.;
    • Zhao, Xiaotian;
    • Reungwetwattana, Thanyanan;
    • Cho, Byoung-Chul;
    • Liao, Bin-Chi;
    • Yeung, Rebecca;
    • Loong, Herbert H.;
    • Kim, Dong-Wan;
    • Yang, James Chih-Hsin;
    • Lim, Sun Min;
    • Ahn, Myung-Ju;
    • Lee, Se-Hoon;
    • Suwatanapongched, Thitiporn;
    • Kongchauy, Kanchaporn;
    • Ou, Qiuxiang;
    • Yu, Ruoying;
    • Tai, Bee Choo;
    • Goh, Boon Cher;
    • Mok, Tony S. K.;
    • Soo, Ross A.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.

    Published in:
    Journal of Neuro-Oncology, 2011, v. 103, n. 3, p. 595, doi. 10.1007/s11060-010-0427-y
    By:
    • Kim, Il;
    • Park, Chul-Kee;
    • Heo, Dae;
    • Kim, Chae-Yong;
    • Rhee, Chang;
    • Nam, Do-Hyun;
    • Lee, Seung;
    • Han, Jung;
    • Lee, Se-Hoon;
    • Kim, Tae;
    • Kim, Dong-Wan;
    • Kim, Jeong;
    • Paek, Sun;
    • Kim, Dong;
    • Kim, In;
    • Kim, Yu;
    • Kim, Jee;
    • Park, Byung-Joo;
    • Jung, Hee-Won
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46

    Back Cover Image.

    Published in:
    InfoMat, 2021, v. 3, n. 11, p. 1, doi. 10.1002/inf2.12267
    By:
    • Sung, Myeong‐Chang;
    • Lee, Gwang‐Hee;
    • Kim, Dong‐Wan
    Publication type:
    Article
    47
    48
    49
    50